Hedge fund manager Whitney Tilson said Exact Sciences (NASDAQ: EXAS) is a great short at $10. Link

Hedge Funds Short Sales Trader Talk

Exact Sciences (EXAS) Drops Another 20%October 8, 2015 11:25 AM Mizuho Securities Cuts Price Target on Exact Sciences (EXAS) to $12 Following USPSTF Cologuard Guidelines October 7, 2015 6:50 AM Lake Street Capital Markets Downgrades Exact Sciences (EXAS) to HoldOctober 6, 2015 1:44 PM Unusual 11 Mid-Day Movers 10/6: (PMCS) (BTU) (ACI) Higher; (EXAS) (RDWR) (TCS) LowerOctober 6, 2015 12:49 PM Exact Sciences (EXAS) PT Lowered to $15 at Roth Capital, Recommends Buying on WeaknessOctober 6, 2015 12:14 PM Exact Sciences (EXAS) PT Slashed to $11 at Goldman Sachs on Negative USPSTF RulingOctober 6, 2015 9:32 AM Pre-Open Stock Movers 10/06: (PMCS) (STRZA) (DD) Higher; (EXAS) (ILMN) (TCS) Lower (more...)October 6, 2015 9:23 AM Canaccord Genuity Reiterates Buy on Exact Sciences (EXAS) Following USPSTF's Draft Recommendation for Colorectal Screening Guidelines October 6, 2015 8:45 AM Benchmark Downgrades Exact Sciences (EXAS) to HoldOctober 6, 2015 8:03 AM Exact Sciences to Host Webcast and Conference Call Regarding U.S. Preventive Services Task Force Draft RecommendationsOctober 6, 2015 7:50 AM USPSTF Draft Recommendation Not as Bullish as Expected for Exact Sciences (EXAS), Wedbush Says; But Would Buy Below $18October 6, 2015 7:25 AM Impact on Exact Sciences (EXAS) from USPSTF Guidlines 'Unclear', Jefferies Says; Would Be Buyers on WeaknessOctober 6, 2015 6:53 AM Exact Sciences (EXAS) Issues Statement on USPSTF Colorectal Cancer Screening Draft RecommendationOctober 6, 2015 6:29 AM Exact Sciences (EXAS) Pleased Cologuard Included in USPSTF Draft Colorectal Cancer Screening GuidelinesOctober 6, 2015 6:28 AM Cologuard® Included as Alternative Screening Test under Draft USPSTF GuidelinesOctober 5, 2015 8:21 PM After Hours Stocks Movers 10/05: (STRZA) (RGLS) (LGF) Higher; (EXAS) (ILMN) (TCS) (more...)October 5, 2015 6:33 PM